Literature DB >> 22070373

Site-specific platinum(II) cross-linking in a ribozyme active site.

Erich G Chapman1, Victoria J DeRose.   

Abstract

The function of RNA depends on its ability to adopt complex and dynamic structures, and the incorporation of site-specific cross-linking probes is a powerful method for providing distance constraints that are valuable in RNA structural biology. Here we describe a new RNA-RNA cross-linking strategy based on Pt(II) targeting of specific phosphorothioate substitutions. In this strategy cis-diammine Pt(II) complexes are kinetically recruited and anchored to a phosphorothioate substitution embedded within a structured RNA. Substitution of the remaining exchangeable Pt(II) ligand with a nucleophile supplied by a nearby RNA nucleobase results in metal-mediated cross-links that are stable during isolation. This type of cross-linking strategy was explored within the catalytic core of the Hammerhead ribozyme (HHRz). When a phosphorothioate substitution is installed at the scissile bond normally cleaved by the HHRz, Pt(II) cross-linking takes place to nucleotides G8 and G10 in the ribozyme active site. Both of these positions are predicted to be within ~8 Å of a phosphorothioate-bound Pt(II) metal center. Cross-linking depends on Mg(2+) ion concentration, reaching yields as high as 30%, with rates that indicate cation competition within the RNA three-helix junction. Cross-linking efficiency depends on accurate formation of the HHRz tertiary structure, and cross-links are not observed for RNA helices. Combined, these results show promise for using kinetically inert Pt(II) complexes as new site-specific cross-linking tools for exploring RNA structure and dynamics.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22070373      PMCID: PMC3257396          DOI: 10.1021/ja206455t

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  76 in total

1.  From alpaca to zebrafish: hammerhead ribozymes wherever you look.

Authors:  Carsten Seehafer; Anne Kalweit; Gerhard Steger; Stefan Gräf; Christian Hammann
Journal:  RNA       Date:  2010-11-16       Impact factor: 4.942

2.  Strategies in RNA crystallography.

Authors:  Francis E Reyes; Andrew D Garst; Robert T Batey
Journal:  Methods Enzymol       Date:  2009-11-17       Impact factor: 1.600

3.  Characterization of a native hammerhead ribozyme derived from schistosomes.

Authors:  Edith M Osborne; Janell E Schaak; Victoria J Derose
Journal:  RNA       Date:  2005-02       Impact factor: 4.942

4.  A new role for cisplatin: probing ribosomal RNA structure.

Authors:  Keshab Rijal; Christine S Chow
Journal:  Chem Commun (Camb)       Date:  2008-11-10       Impact factor: 6.222

5.  Biophysical, chemical, and functional probes of RNA structure, interactions and folding: Part A. Preface.

Authors:  Dan Herschlag
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 6.  Model systems: how chemical biologists study RNA.

Authors:  Andro C Rios; Yitzhak Tor
Journal:  Curr Opin Chem Biol       Date:  2009-10-29       Impact factor: 8.822

Review 7.  Rapid global structure determination of large RNA and RNA complexes using NMR and small-angle X-ray scattering.

Authors:  Yun-Xing Wang; Xiaobing Zuo; Jinbu Wang; Ping Yu; Samuel E Butcher
Journal:  Methods       Date:  2010-06-08       Impact factor: 3.608

8.  A simple procedure for cross-linking complementary oligonucleotides.

Authors:  B C Chu; L E Orgel
Journal:  DNA Cell Biol       Date:  1990 Jan-Feb       Impact factor: 3.311

9.  Topography of the Escherichia coli initiation factor 2/fMet-tRNA(f)(Met) complex as studied by cross-linking.

Authors:  G Yusupova; J Reinbolt; H Wakao; S Laalami; M Grunberg-Manago; P Romby; B Ehresmann; C Ehresmann
Journal:  Biochemistry       Date:  1996-03-05       Impact factor: 3.162

Review 10.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

View more
  2 in total

1.  Interstrand cross-link and bioconjugate formation in RNA from a modified nucleotide.

Authors:  Jack L Sloane; Marc M Greenberg
Journal:  J Org Chem       Date:  2014-10-08       Impact factor: 4.354

2.  Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome.

Authors:  Sergey V Melnikov; Dieter Söll; Thomas A Steitz; Yury S Polikanov
Journal:  Nucleic Acids Res       Date:  2016-04-13       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.